Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Open — responses due 30 Nov 2026 (16 days left) · Unrestricted (full and open) · Defense Health Agency (DHA), DoD · San Antonio, TX · NAICS 325412 · Solicitation HT9402-27-Q-9102

Get the compliance matrix for this solicitation. Every requirement an offer must meet, each cited to the page it came from. Free, no account.

Build the compliance matrixor get the quick AI read of what is being bought and the deal-breakers

Solicitation details

Solicitation numberHT9402-27-Q-9102
Notice IDfe90f9ebb8f44bb798775e53a965c877
AgencyDepartment of Defense (DoD)
Sub-agencyDefense Health Agency (DHA)
Contracting officeDEFENSE HEALTH AGENCY
NAICS code325412 — Pharmaceutical Preparation Manufacturing
Product / service code (PSC)6505
Set-asideUnrestricted (full and open)
Notice typeSolicitation
Posted12 November 2026
Response deadline30 November 2026
Place of performanceSan Antonio, TX, USA
CompetitionCompetitive

Get the compliance matrix for this solicitation

FedSift reads every document in the package and lists every requirement an offer must meet — submission instructions, certifications, deadlines, hard gates — each cited to the page it came from. Free, no account.

Takes a few minutes for most packages — we can email it to you.

AI read of this solicitation

Before you spend a day on this package: FedSift reads every document and pulls out what is being bought, the deal-breakers and the key risks — each quoted from the page it came from. Free, no account needed. The result is shared, so the next reader gets it instantly. With a free account it also builds the full compliance matrix.

Track this solicitation

We'll email you if the response deadline moves, an amendment posts, or new documents are added. It closes 30 November 2026. No account needed — one email, unsubscribe in a click.

Description

The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: The following February 2027 newly approved drugs will be reviewed: Atebrioz – Skeletal Muscle Relaxants and Combinations – Subclass: NA Emcitate – Thyroid and Antithyroid Agents – Subclass: NA Hibsago – Hepatitis B Agents – Subclass: NA Juvmo – Parkinsons Agents – Subclass: NA Zegfrovy – Lung Cancer – Subclass: EGFR+ NSCLC The RFQ, including UF BPA and UF ADP appendices, are attached herein. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-27-Q-9102. Pre-quotation teleconference is on November 17, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.

Documents in the solicitation package

10 files are attached to this notice.

  • RFQ HT9402-27-Q-9102 NAD.pdf
  • Price List - Atebrioz - Skeletal Muscle Relaxants and Combinations - NA.xlsx
  • Price List - Emcitate - Thyroid and Antithyroid Agents - NA.xlsx
  • Price List - Hibsago - Hepatitis B Agents - NA.xlsx
  • Price List - Juvmo - Parkinsons Agents - NA.xlsx
  • Price List - Zegfrovy - Lung Cancer - EGFR NSCLC.xlsx
  • FAR 52-225-6-Certificate.pdf
  • DoD Formulary Placement of FDA Newly Approved Drugs.pdf
  • Price Appendix FAQ NAD.pdf
  • https://health.mil/PandT

Download all 10 files as one ZIPFree account, no credit card.

Build the compliance matrix from these 10 files

Every requirement, cited to the page it came from — free.

Or download them one at a time from SAM.gov.

Go deeper on this solicitation

FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.

Open the AI analysis in FedSift →

Free forever plan — no credit card. Browse solicitations without an account; sign in for AI analysis and matching.

Market context: DoD and NAICS 325412

About the buyer and the industry, not this specific solicitation. Source: USASpending.gov award data, updated nightly.

  • In fiscal year 2026, DoD obligated $70.4M across 10,537 contract actions under NAICS 325412.
  • 15 contracts worth $4.4M in this category end within the next 18 months.

DoD contracts under NAICS 325412 →

Other open solicitations in NAICS 325412

All NAICS 325412 solicitations →

More from Department of Defense

All DoD solicitations →

Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.

FedSift turns SAM.gov and USASpending data into federal BD intelligence — smart matches, recompete radar, cited AI solicitation analysis and compliance matrices.

Source data: SAM.gov (solicitations) and USASpending.gov (awards), refreshed nightly. FedSift is not affiliated with the U.S. Government.

Pricing · Privacy · Terms · support@fedsift.app